Recomendaciones sobre enfermedad tromboembólica venosa en procesos oncológicos. Una visión desde la medicina de familia(Pag.-e 102030)

  1. O. García Vallejo 1
  2. M.D. Aicart Bort 2
  3. M.Á. Babiano Fernández 3
  4. J. Caballer Rodilla 4
  5. M.Á. Cabrera Ferriols 5
  6. E. Carrasco Carrasco 6
  7. I. Gil Gil 7
  8. A.M. Lahera García 8
  9. T. Martos Cárdenas 9
  10. A. Piera Carbonell 10
  1. 1 Centro de Salud Comillas, Madrid, España
  2. 2 Medicina Familiar y Comunitaria, Castellón, España
  3. 3 Centro de Salud Argamasilla de Calatrava, Argamasilla de Calatrava, Ciudad Real, España
  4. 4 Centro de Salud Algete, Algete, Madrid, España
  5. 5 Medicina Familiar y Comunitaria, Alicante, España
  6. 6 Centro de Salud de Abarán, Abarán, Murcia, España
  7. 7 Centro de Salud Vielha, Vielha, Lleida, España
  8. 8 Hospital Universitario de Getafe, Getafe, Madrid, España
  9. 9 Hospital del Mar, Barcelona, España
  10. 10 Centro de Salud Corredoria, Oviedo, Asturias, España
Mostrar afiliaciones +
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Año de publicación: 2023

Número: 7

Páginas: 7-7

Tipo: Artículo

DOI: 10.1016/J.SEMERG.2023.102030 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Semergen: revista española de medicina de familia

Resumen

La enfermedad tromboembólica venosa (ETV) es una complicación frecuente en pacientes diagnosticados de cáncer, y una causa importante de morbimortalidad. Aproximadamente el 30% de los episodios tromboembólicos se desarrollan en relación con un cáncer activo. Se estima que alrededor del 2-12% de los casos el episodio tromboembólico es la primera manifestación de un cáncer oculto, diagnosticado en ese momento o con posterioridad, lo que ofrece una oportunidad para su diagnóstico y tratamiento precoces. Existen múltiples factores que contribuyen a aumentar el riesgo de ETV en pacientes oncológicos en relación con características específicas del paciente, del tumor y de los tratamientos. Conocer estos factores de riesgo (FR) contribuirá al diagnóstico precoz cuando aparezcan signos de ETV, así como al inicio de la tromboprofilaxis si estuviera indicada. El diagnóstico de ETV en pacientes con cáncer no difiere del de los que no lo padecen. En cuanto al tratamiento de la ETV en estos pacientes, la heparina de bajo peso molecular (HBPM), los anticoagulantes de acción directa (ACOD) y los antivitamina K (AVK) son los más empleados, aunque no está claro todavía el régimen posológico ni la duración. El manejo de estos pacientes debe ser interdisciplinar y precoz, por lo que el médico de familia juega un papel fundamental en este proceso al estar en contacto continuo con sus pacientes. También es necesaria una actualización de conocimientos que mejoren la atención a estos enfermos. Por estos motivos se ha elaborado este documento desde el Grupo de Trabajo de Vasculopatías de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN), cuyo objetivo es presentar la información disponible en relación con el manejo de la ETV que puede aparecer en pacientes oncológicos, así como valorar la tromboprofilaxis y el tratamiento, si procede, desde un enfoque centrado en el ámbito de nuestra práctica clínica habitual.

Referencias bibliográficas

  • A.R. Lyon, T. López-Fernández, L.S. Couch, R. Asteggiano, M.C. Aznar, J. Bergler-Klein, et al., 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Eur Heart J., 43 (2022), pp. 4229-4361 View PDF This article is free to access. CrossRefView in Scopus
  • J.W. Blom, C.J. Doggen, S. Osanto, F. Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA, 293 (2005), pp. 715-722 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • A.J. Muñoz, E. Gallardo, I. García, R. Macías, V. Martínez, M. Pachón, et al. SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019) Clin Transl Oncol, 22 (2020), pp. 171-186 View in ScopusGoogle Scholar
  • Salvador C, Segura A. Modelos predictivos de riesgo de enfermedad tromboembólica venosa. SEOM (Sociedad Española de Oncología Médica) 2019 [consultado 23 Oct 2022] Disponible en: https://gallery.mailchimp.com/b0d8b14b096130daf62d315a8/files/68f390f7-161b-4a58-9eb3-bfc1d1b2a3a3/Modelos_predictivos_de_riesgo_ETV.pdf Google Scholar
  • D. Farge, C. Frere, J.M. Connors, A.A. Khorana, A. Kakkar, C. Ay, et al. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 Lancet Oncol, 23 (2022), pp. e334-e347 View PDFView articleView in ScopusGoogle Scholar
  • A.K. Kakkar, M. Levine, H.M. Pinedo, R. Wolff, J. Wong Venous thrombosis in cancer patients: Insights from the FRONTLINE survey Oncologist, 8 (2003), pp. 381-388 View PDF This article is free to access. View in ScopusGoogle Scholar
  • A.K. Kakkar, R. Bauersachs, A. Falanga, J. Wong, G. Kayani, A. Kahney, et al. Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey Oncologist, 25 (2020), pp. e1091-e1097 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • O. García Vallejo, M. Frías Vargas, E. Carrasco Carrasco, M.A. Babiano Fernández, P. Padilla Sáez Enfermedad Tromboembólica y cáncer. ¿Tenemos presente esta relación en nuestra práctica clínica habitual? Comunicación virtual presentada en 12 Jornadas cardiovasculares SEMERGEN (2021), pp. 12-17 Google Scholar
  • S. Dhami, S. Patmore, J.M. O'Sullivan Advances in the Management of Cancer Associated Thrombosis Semin Thromb Hemost, 47 (2021), pp. 139-149 View in ScopusGoogle Scholar
  • P. Martínez del Prado, D. Isla Casado Epidemiología, etiopatogenia, factores de riesgo y pronóstico de la ETV. Diagnóstico de la ETV: TEP, TVP y trombosis asociada a catéter. En: II Consenso SEOM sobre Enfermedad Tromboembólica en Pacientes con cáncer (2013) [consultado 21 Dic 2022] Disponible en: https://www.seom.org/seomcms/images/stories/recursos/II_Consenso_SEOM_enf_tromboembolica_cancer.pdf
  • T. Wun, R.H. White Epidemiology of cancer-related venous thromboembolism Best Pract Res Clin Haematol, 22 (2009), pp. 9-23 View PDFView articleView in ScopusGoogle Scholar
  • H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med, 343 (2000), pp. 1846-1850 View in ScopusGoogle Scholar
  • M.S. Hamza, S.A. Mousa Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management Clin Appl Thromb Hemost, 26 (2020), pp. 1-13 View article CrossRefGoogle Scholar
  • A.A. Khorana, N.M. Kuderer, E. Culakova, G. Lyman, C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood, 111 (2008), pp. 4902-4907 View PDFView articleCrossRefView in ScopusGoogle Scholar
  • D. Barrios, L. Jara, D. Jimenez Venous Thromboembolic Disease and Cancer: A Challenge for Clinicians Arch Bronconeumol, 54 (2018), pp. 359-360 View PDFView articleView in ScopusGoogle Scholar
  • L. Gervaso, H. Dave, A.A. Khorana Venous and Arterial Thromboembolism in Patients with Cancer JACC: CardioOncology State-of-the-Art Review JACC Cardi Oncol, 3 (2021), pp. 173-190 View PDFView articleView in ScopusGoogle Scholar
  • M.L. Louzada, H. Majeed, V. Dao, P.S. Wells Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: A systematic review of observational and intervention studies Blood Coagul Fibrinolysis, 22 (2011), pp. 86-91 View in ScopusGoogle Scholar
  • C. Ay, D. Dunkler, C. Marosi, A.L. Chiriac, R. Vormittag, R. Simanek, et al. Prediction of venous thrombolism in cancer patients Blood, 116 (2010), pp. 5377-5382 View PDFView articleCrossRefView in ScopusGoogle Scholar
  • M. Ferrer Galván, V. Sánchez López, R. Otero Candelera Factores predictores de trombosis en pacientes con cáncer Arch Bronconeumol, 55 (2019), pp. 67-76 View PDF Your institution provides access to this article. View in ScopusGoogle Scholar
  • G. Agnelli, G. Gussoni, C. Bianchini, M. Verso, M. Mandalà, L. Cavanna, et al. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: A randomised, placebo-controlled, double-blind study Lancet Oncol, 10 (2009), pp. 943-949 View PDFView articleView in ScopusGoogle Scholar
  • U. Pelzer, B. Opitz, G. Deutschinoff, M. Stauch, P.C. Reitzig, S. Hahnfeld, et al. Efficacy of Prophylactic Low-Molecular-Weight Heparin for Ambulatory Patients with Advanced Pancreatic Cancer: Outcomes from the CONKO-004 Trial J Clin Oncol, 33 (2015), pp. 2028-2034 View in ScopusGoogle Scholar
  • G.T. Gerotziafas, A. Taher, H. Abdel-Razeq, E. AboElnazar, A.C. Spyropoulos, S. El Shemmari, et al. A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: The prospective COMPASS-Cancer-Associated Thrombosis study Oncologist, 22 (2017), pp. 1222-1231 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • B. Campos, E. Fernández, C. Barbagelata, E. Brozos, I. Carou, I. Fernández, et al. Guía gallega de manejo de la trombosis asociada a cáncer Sociedad Oncológica de Galicia (II edición), Bubblegum Communication Services SL, Barcelona (2019) ISBN: 978-84-09-1419-4. Google Scholar
  • J. Hendriksen, G. Geersing, W. Lucassen, P. Erkens, H. Stoffers, H. van Weert, et al. Diagnostic prediction models for suspected pulmonary embolism: Systematic review and independent external validation in primary care BMJ, 351 (2015), p. h4438 View article CrossRefView in ScopusGoogle Scholar
  • A.J. Muñoz, I. Ortega, C. Font, V. Pachón, V. Castellón, V. Martínez, et al. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer Br J Cancer, 118 (2018), pp. 1056-1061 Google Scholar
  • N. Barja González Anticoagulación oral en trombosis asociada a cáncer Blog (2021) Sociedad española de cardiología [consultado 10 Nov 2022] Disponible en: https://secardiologia.es/blog/11612-anticoagulacion-oral-en-trombosis-asociada-a-cancer Google Scholar
  • F.I. Mulder, M. Candeloro, P.W. Kamphuisen, M. Di Nisio, P.M. Bossuyt, N. Guman, et al. The Khorana score for prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis Haematologica, 104 (2019), pp. 1277-1287 View article CrossRefView in ScopusGoogle Scholar 29 Mondéjar Solis R, Obispo Portero B. Trombosis venosa superficial y cáncer. 2018 SEOM (Sociedad Española de Oncología Médica) [concultado 21 Nov 2022] Disponible en: https://seom.org/seomcms/images/stories/recursos/Trombosis_venosa.pdf Google Scholar
  • M.B. Streiff, B. Holmstrom, D. Angelini, A. Ashrani, P. Bockentedt, C. Chesney, et al. Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. Featured Updates to the NCCN Guidelines J Natl Compr Canc Netw, 16 (2018), pp. 1289-1303 View article CrossRefView in ScopusGoogle Scholar
  • J. Beyer-Westendorf Controversies in venous thromboembolism: To treat or not to treat superficial vein thrombosis Hematology Am Soc Hematol Educ Program, 2017 (2017), pp. 223-230 View article CrossRefView in ScopusGoogle Scholar
  • S.M. Stevens, S.C. Woller, L. Baumann, H. Bounameaux, K. Doerschug, G.J. Geersing, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report CHEST, 160 (2021), pp. e545-e608 View PDFView articleView in ScopusGoogle Scholar
  • S. Konstantinides, G. Meyer, C. Becattini, H. Bueno, G.J. Geersing, V.P. Harjola, et al., [2019] ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) Eur Heart J, 41 (2020), pp. 543-603 View PDF This article is free to access. CrossRefView in Scopus
  • L. Mazzolai, W. Ageno, A. Alatri, R. Bauersachs, C. Becattini, M. Brodman, et al., Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function Eur J Prev Cardiol, 29 (2022), pp. 1248-1263 View PDF This article is free to access. CrossRefView in Scopus
  • S.Z. Goldhaber, H. Bounameux Pulmonary embolism and deep vein thrombosis Lancet, 379 (2013), pp. 1835-1846 Google Scholar
  • S.K. Kakkos, M. Gohel, N. Baekgaard, R. Bauersachs, S. Bellmunt-Montoya, S.A. Black, et al. European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis Eur J Vasc Endovasc Surg, 61 (2021), pp. 9-82 View PDFView articleView in ScopusGoogle Scholar
  • M.B. Streiff, B. Holmstrom, D. Angelini, A. Ashrani, A. Elshoury, J. Fanikos, et al., Cancer associated Venous Thromboembolic Disease NCCN Clinical Practice Guidelines in Oncology J Natl Compr Canc Netw, 19 (2021), pp. 1181-1201 View in ScopusGoogle Scholar
  • N.S. Key, A.A. Khorana, N.M. Kuderer, K. Bohlke, A.Y.Y. Lee, J.I. Arcelus, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Clinical Practice Guideline Update J Clin Oncol, 38 (2020), pp. 496-520 View article CrossRefView in ScopusGoogle Scholar
  • G. Lyman, M. Carrier, C. Ay, M. Di Nisio, L.K. Hicks, A.A. Khorana, et al., American Society of Hematology 2021 guidelines for management of venous thromboembolism: Prevention and treatment in patients with cancer Blood adv, 5 (2021), pp. 927-974 View PDFView articleCrossRefView in Scopus
  • J. Portillo Profilaxis de la enfermedad tromboembólica en pacientes con cáncer Rev Clin Esp, 220 (Supl 1) (2020), pp. 17-24 View article CrossRefGoogle Scholar
  • V. Pachón, J. Trujillo, P. Domènech, E. Gallardo, C. Font, J.R. González, et al. Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines—A Multidisciplinary (SEMI–SEOM–SETH) Expert Consensus TH Open, 2 (2018), pp. 373-386 Google Scholar
  • Fernández I, Teijeira L. Trombosis y cáncer. Tratamiento más allá de 6 meses y dosis. SEOM 2020 [consultado 20 Nov 2022] Disponible en: https://seom.org/images/SEOM_Trombosis_y_cancer_Fernandez_Teijeira.pdf) Google Scholar
  • Berros JP, Pérez J. Evaluación del riesgo hemorrágico en el paciente con cáncer. SEOM 2022 [consultado 7 Dic 2022] Disponible en: https://seom.org/formacion/formacion-on-line/revisiones-cientificas/209639-evaluacion-del-riesgo-hemorragico-en-el-paciente-con-cancer Google Scholar
  • P.L. Den Exter, S.C. Woler, H. Robert-Ebadi, C. Masias, P.E. Morange, D. Castelli, et al. Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease J Thromb Haemost, 20 (2022), pp. 1910-1919 View PDFView articleCrossRefView in ScopusGoogle Scholar
  • F.A. Klok, V. Hösel, A. Clemens, W.D. Yollo, C. Tilke, S. Schulman, et al. Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Eur Respir J, 48 (2016), pp. 1369-1376 View article CrossRefView in ScopusGoogle Scholar
  • N. Ruíz-Giménez, C. Suárez, R. González, J.A. Nieto, J.A. Todolí, A.L. Samperiz, et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE registry Thromb Haemost, 100 (2008), pp. 26-31 View in ScopusGoogle Scholar
  • C. Becattini, M. Di Nisio, L. Franco, A. Lee, G. Agnelli, M. Mandalà Treatment of venous thromboembolism in cancer patients: The dark side of the moon Cancer Treat Rev, 96 (2021), pp. 102-190 Google Scholar
  • Hernández A, Font C. Recurrencia del tromboembolismo venoso en paciente oncológico: ¿se puede predecir? ¿cómo manejarla? SEOM 2016 [consultado 11 Dic 2022] Disponible en: https://seom.org/formacion/formacion-on-line/revisiones-cientificas/105818-recurrencia-de-tromboembolismo-venoso-en-el-paciente-oncologico-ise-puede-predecir-icomo-manejarla Google Scholar
  • K.M. SanFilippo, F. Moik, M. Candeloro, C. Ay, M. Di Nisio, A.Y.Y. Lee Unanswered questions in cancer-associated thrombosis Br J Haematol, 198 (2022), pp. 812-825 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • A.A. Khorana, R. Bauersachs, P. Kamphuisen, G. Meyer, M. Janas, A. Lee, Catch investigators Clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients from a randomized trial of long-term tinzaparin versus warfarin for treatment: The CATCH study J Clin Oncol, 33 (Suppl 15) (2015), p. 9621 Google Scholar
  • G. Meyer, Z. Marjanovic, J. Valcke, B. Lorcerie, Y. Gruel, P. Solal-Celigny, et al. Comparison of low molecular weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study Arch Intern Med, 162 (2002), pp. 1729-1735 View PDF This article is free to access. View in ScopusGoogle Scholar
  • A.Y. Lee, M.N. Levine, R.I. Barker, C. Bowden, A.K. Kakkar, M. Prins, et al., Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators N Engl J Med, 349 (2003), pp. 146-153 View in Scopus
  • C. Kearon, E.A. Akl, J. Ornelas, A. Blaivas, D. Jimenez, H. Bounameaux, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report Chest, 149 (2016), pp. 315-352 View PDFView articleView in ScopusGoogle Scholar
  • P. Jiménez, E. Gallardo, F. Arranz, J.M. Blanco, A. Callejo, D. Cacho, et al. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence Eur J Intern Med, 100 (2022), pp. 33-45 Google Scholar
  • Calzas J, Gutiérrez D. Tromboembolismo incidental en pacientes con cáncer. SEOM 2016 [consultado 11 Dic 2022] Disponible en: https://www.seom.org/seomcms/images/stories/recursos/Tromboembolismo_incidental_SEOM.pdf Google Scholar
  • B.T. Samuelson, A. Lee, A.A. Khorana, J.I. Zwicker, S. Noble, C. Ay, et al. Management of cancer-associated thrombosis in patients with thrombocytopenia: Guidance from the SSC of the ISTH J Thromb Haemost, 16 (2018), pp. 1246-1249 Google Scholar
  • A. Falanga, C. Ay, M. Di Nisio, G. Gerotziafas, L. Jara-Palomares, F. Langer, et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline Ann Oncol., 34 (2023), pp. 452-467 View PDFView articleView in ScopusGoogle Scholar
  • J.A. Nieto, R. Solano, M.D. Ruiz-Ribó, N. Ruiz-Gimenez, P. Prandoni, C. Kearon, et al. Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: Findings from the RIETE registry J Thromb Haemost, 8 (2010), pp. 1216-1222 View PDFView articleCrossRefView in ScopusGoogle Scholar
  • T. Tritschler, A. Castellucci, N. Es, D. Aujesky, G. Le Gal Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants Polish Arch Intern Med, 130 (2020), pp. 529-538 View in ScopusGoogle Scholar
  • I. Ayalon, Y. Vega, M. Rozi, A. Grossman, G. Spectre, T. Schocat, et al. Outcome of Elderly Patients with Venous Thromboembolism Treated with Direct Oral Anticoagulants—A Retrospective Cohort Study J Clin Med, 10 (2021), p. 5673 Google Scholar
  • E. Casco Aguilar, M. Bravo Ruiz, L. Izagirre Loroño, N. Estallo Laliena, Á. de la Fuente Sánchez Barba Vélez Neoplasia oculta en pacientes con trombosis venosa profunda esencial de extremidades inferiors Angiología, 63 (2011), pp. 103-150 Google Scholar
  • A. Delluc, D. Antic, R. Lecumberri, C. Ay, G. Meyer, M. Carrier Occult cancer screening in patients with venous thromboembolism: Guidance from the SSC of the ISTH J. Thromb. Haemost, 15 (2017), pp. 2076-2079, 10.1111/jth.13791 View PDFView articleView in ScopusGoogle Scholar
  • J. D’Astous, M. Carrier Screening for Occult Cancer in Patients with Venous Thromboembolism J Clin Med, 9 (2020), p. 2389 View article CrossRefGoogle Scholar
Fuente de los datos: Dialnet